TrialMalaria journal2020

An open label study of the safety and efficacy of a single dose of weekly chloroquine and azithromycin administered for malaria prophylaxis in healthy adults challenged with 7G8 chloroquine-resistant Plasmodium falciparum in a controlled human malaria infection model.

Jeffrey Livezey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.